848 studies found for:    Open Studies | "Insulin"
Show Display Options
Rank Status Study
1 Recruiting Insulin Therapy for Post-transplant Glucocorticoid Induced Hyperglycemia
Condition: Post-Transplant Glucocorticoid Induced Diabetes
Interventions: Drug: Neutral protamine hagedorn (NPH) insulin;   Drug: Regular human insulin or Insulin Aspart;   Drug: Insulin glargine
2 Recruiting Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes
Condition: Diabetes During Pregnancy
Interventions: Drug: NPH;   Drug: Insulin LISPRO;   Drug: Insulin glulisine
3 Recruiting Sensor-Augmented Insulin-Pump Therapy in New-onset Diabetes After Transplantation
Condition: Hyperglycemia
Interventions: Drug: Insulin lispro, Humalog (Eli Lilly) in insulin pump;   Drug: Human insulin isophane, Humulin N (Eli Lilly);   Other: Standard of care
4 Unknown  PK/PD Study of Intranasal Insulin in Type I Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Insulin;   Drug: Insulin LISPRO
5 Not yet recruiting The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study
Conditions: Diabetes Mellitus, Type 2;   Diabetes
Interventions: Drug: Metformin;   Drug: Detemir;   Drug: Liraglutide;   Drug: Insulin Aspart
6 Not yet recruiting Cystic Fibrosis (CF) Exacerbation and Insulin Treatment
Conditions: Cystic Fibrosis;   Impaired Glucose Tolerance;   Pulmonary Exacerbation
Interventions: Drug: novorapid / humalog short acting insulin;   Drug: Novo Rapid Insulin (Novonordisk)
7 Unknown  Establishing Cardiovascular Biomarkers to Define Preferred Lantus® Use
Condition: Insulin-requiring Type 2 Diabetes Mellitus
Interventions: Drug: nph insulin;   Drug: human insulin;   Drug: Insulin Glargine;   Drug: Insulin glulisine
8 Unknown  Various Insulin Regimens for Diabetic Inpatients With Cirrhosis Trial
Conditions: Type 2 Diabetes;   Liver Cirrhosis
Interventions: Drug: Glargine & Glulisine;   Drug: Regular insulin;   Drug: NPH & regular insulin
9 Unknown  Glycemic Effects of Morning Only, Evening Only or Twice Daily Insulin Glargine in Patients With Type 1 Diabetes
Conditions: Type 1 Diabetes;   Hypoglycemia
Interventions: Drug: Evening only administration of insulin glargine;   Drug: Morning only administration of insulin glargine;   Drug: split dose insulin glargine
10 Unknown  The Effect of Central Insulin on Insulin Sensitivity and Energy Metabolism
Condition: Diabetes
Interventions: Drug: central insulin;   Drug: Placebo
11 Unknown  Study of Combination Therapy of Gliclazide MR and Basal Insulin Versus Insulin Monotherapy to Treat Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Gliclazide MR and Insulin Glargine Injection;   Drug: Biosynthetic Human Insulin Injection
12 Unknown  Comparing Long-acting Insulins During Exercise in Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Insulin glargine;   Drug: Insulin detemir
13 Recruiting A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Interventions: Drug: insulin degludec/liraglutide;   Drug: insulin aspart
14 Unknown  Glucose Insulin Potassium With Intensive Insulin Therapy and (GIK2) Versus GIK Alone
Condition: Acute Coronary Syndrome
Interventions: Drug: glucose insulin potassium;   Drug: GIK and intensive insulin therapy
15 Recruiting A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus
Conditions: Diabetes;   Diabetes Mellitus, Type 1
Interventions: Drug: insulin degludec/insulin aspart;   Drug: insulin aspart;   Drug: insulin detemir
16 Recruiting Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Interventions: Drug: insulin aspart (FIAsp);   Drug: insulin aspart;   Drug: insulin glargine
17 Recruiting TReatment by Insulin Continuous Infusion in Type 2 DIAbetes
Condition: Diabetes
Intervention: Drug: 2 different procedures of administration of insulin
18 Recruiting Glycemic Control Using Insulin Levemir Versus Insulin NPH for Diabetes in Pregnancy
Conditions: Diabetes, Gestational;   Diabetes, Type 2
Intervention: Drug: Insulin
19 Recruiting Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting
Condition: Type 1 Diabetes
Interventions: Device: Closed loop with enlite sensors, insulin, liraglutide;   Device: Closed loop with enlite sensors, insulin
20 Recruiting Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Intermittent insulin therapy;   Drug: Continuous metformin

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years